Mini Review Open Access
Volume 6 | Issue 1 | DOI: https://doi.org/10.33696/Gastroenterology.6.058
Gastrointestinal Reflux Related Aspiration (GRASP) and Airway Injury after Lung Transplantation: Insights into Pathophysiology and Role of Airway Biomarkers for Risk Stratification
Miguel M. Leiva-Juarez, MD, MSE1,2, Frank D’Ovidio, MD, PhD1,*
- 1Lung Transplant Program, Columbia University Irving Medical Center, New York, NY, USA
- 2Department of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Corresponding Author
Frank D’Ovidio, fd2133@cumc.columbia.edu
Received Date: October 16, 2024
Accepted Date: December 09, 2024
Leiva-Juárez MM, D’Ovidio F. Gastrointestinal Reflux Related Aspiration (GRASP) and Airway Injury after Lung Transplantation: Insights into Pathophysiology and Role of Airway Biomarkers for Risk Stratification. Arch Gastroenterol Res. 2025;6(1):1-7.
Copyright: © 2025 Leiva-Juárez MM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Do Support Vector Machines Play a Role in Stratifying Patient Population Based on Cancer Biomarkers
Cancer is a worldwide public health issue that affects millions of people every year. In 2018 there were 17 million newly documented cases of cancer globally (8.8 million in men and 8.2 million in women), leading to 9.6 million deaths. Cancer is a vastly heterogeneous disease, with over 100 different types of cancer currently identified in humans; the most common types of cancer are lung, female breast, bowel and prostate, these four types account for more than 40% of all new cancer case
Salivary Protein Antigens for Breast Cancer Biomarkers
Breast Cancer is the most regularly diagnosed type of cancer in women in the world, making up on its own 25% of all cases, or nearly 2 million new cases in 2018, and 15% of all cancer related deaths, or around 626,700 deaths for that same year.
Gastrointestinal Manifestations of COVID-19: An Overview
The Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the new coronavirus of severe acute respiratory syndrome 2 (SARS-CoV-2), single-stranded, positive sense, spherical RNA virus with spikes protein that protrude on its surface giving the appearance of a crown, from the Latin corona. It belongs to the large family of coronaviruses (CoVs) and the genus β-coronavirus. COVID-19 can involve manifestations in the respiratory system, as well as other biological systems, as a intestinal.
Obeticholic Acid, FXR Agonists, Liver Disease and Plasma Biomarkers
How medications whose major biologic effect is to reduce bile acid synthesis favorably affect the course of a variety of cholestatic and metabolic liver diseases is not immediately apparent. Also, the most frequently used plasma biomarkers for evaluating benefit, alkaline phosphatase and conjugated bilirubin [1], provide different information. The former may be misleading with respect to the course of the disease and therefore it is important to focus on the pathophysiologic basis for its use.
Long Non-coding RNAs in the Pathophysiology of Multiple Myeloma New Insights on the Role of CRNDE
Over the past 15 years, long non-coding RNAs (lncRNA) have emerged as an important class of regulatory molecules. The currently accepted definition is that lncRNA refers to RNA molecules with little or no protein-coding potential, and which are greater than 200 nucleotides in length, a size cut-off chosen largely to distinguish them from the more-extensively characterised group of small non-coding regulatory RNAs, which includes micro (mi)RNAs, small inhibitory (si)RNAs and PIWI-interacting (pi)RNAs.